In this issue:
Baricitinib: acceptable safety profile
Immediate- vs extended-release febuxostat in gout
eight loss benefits obese patients with PsA
Examining dose reduction for long-term TNFi in axSpA
Adipose tissue grafting induces IDU healing in SSc
Deciding whether to continue treatment with tofacitinib MTX ± HCQ in early RA
Support lacking for an MRI-guided treatment strategy in RA
Etanercept vs MTX alone or in combination for PsA
MMF vs cyclophosphamide for remission induction in AAV
Please login below to download this issue (PDF)